Where Contrast Administration Makes a Difference Contrast 2017 State of the Art

Size: px
Start display at page:

Download "Where Contrast Administration Makes a Difference Contrast 2017 State of the Art"

Transcription

1 Where Contrast Administration Makes a Difference Contrast 2017 State of the Art Linda D. Gillam, MD, MPH, FASE Chair, Cardiovascular Medicine Medical Director, CV Service Line Morristown Medical Center/Atlantic Health System Morristown, NJ Professor of Medicine Thomas Jefferson University No disclosures 1

2 Contemporary Ultrasound Contrast Agents Stabilized gas microspheres sized to pass through the smallest capillaries Microsphere: 2-5 m RBC: 6-8 m Burns. In: Rumack et al, eds. Diagnostic Ultrasound. Vol 1. 2nd ed. St. Louis: Mosby; 1998:57. Currently available agents 2

3 Interaction of Ultrasound and Microbubbles Linear resonance Nonlinear resonance Transient scattering POWER POWER Fundamental enhancement POWER Harmonic enhancement Bubble disruption Burns. In Rumack et al, eds. Diagnostic Ultrasound. Vol. 1. 2nd ed. St. Louis: Mosby; 1998:57. Principles of Harmonic Imaging Tissue and blood reflect at the fundamental frequency 2.5 MHz Microbubbles reflect at both the fundamental and the harmonic frequencies 2.5 MHz 2.5 MHz 2.5 MHz + 5 MHz Burns. In Rumack et al, eds. Diagnostic Ultrasound. Vol. 1. 2nd ed. St. Louis: Mosby; 1998:57. 3

4 Fundamental and Harmonic Contrast Imaging Tissue Contrast Schrope and Newhouse. Ultrasound Med Biol. 1993;19:567. Shapiro et al. Am J Roentgenol. 1998; 171: It s all about signal to noise! 4

5 Machine Settings For most applications Aim to maximize non-linear harmonic reflecting responses (MI ) Improves signal to noise vs tissue Equipment Optimized settings (presets) Contrast agent specific Transducer specific For perfusion applications Controlled bubble destruction Works best with equipment specifically equipped to do perfusion imaging Outcomes Cost effectiveness Impact on therapeutic strategy Impact on diagnostic and prognostic thinking Diagnostic capacity Technical capability and Operational excellence Guyatt GH, Tugwell PX, Feeny DH, Haynes RB, Drummond M. A framework for clinical evaluation of diagnostic technologies. CMAJ 1986; 134: Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making 1991; 11:

6 Outcomes Cost effectiveness Rx: Devices/ intervention for AS Prognosis/dx related to LV function and gradients LVEF, Quantitation of gradients LVO/EBD, Doppler enhancement Guyatt GH, Tugwell PX, Feeny DH, Haynes RB, Drummond M. A framework for clinical evaluation of diagnostic technologies. CMAJ 1986; 134: Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making 1991; 11:

7 7

8 8

9 Case Examples Left Ventricular Opacification 62 yo female with aortic and mitral valve disease Is the EF <60% Accurate LVEF needed for clinical decision making 9

10 10

11 11

12 LVEF 64% Stress echo 12

13 With thanks to Sharon Mulvagh 62 yo female with atrial fibrillation (spontaneously converted) and dyspnea 13

14 14

15 Dx: Apical HCM Not CAD Another myopathy 15

16 With thanks to Sharon Mulvagh, MD Mulvagh: J Am Soc Echocardiogr 21:1179, yo male with NYHA Class III Heart Failure 16

17 17

18 76 yo female with syncope 18

19 4.4mps 19

20 32 yo male with atrial fibrillation and family history of SCD 20

21 21

22 Dx: ARVD 22

23 Myocardial Contrast Perfusion Thanks to Tom Porter, MD Post PCI Thanks to Tom Porter 23

24 Safety Concerns 24

25 Class Box Warning Old contraindications 25

26 Current for all agents Lumason and pediatric 26

27 CARPA Complement Activation Related Pseudo-Allergy CARPA Signs and Symptoms Angioedema Bronchospasm Cyanosis Hypotension Low back pain Pruritis Urticaria Tingling sensation Hypoxemia Sneezing 27

28 Acute Hypersensitivity Reactions IgE mediated type I Reaction after repeated exposure Reaction is stronger upon repeated exposure Reaction does not cease without treatment CARPA No prior exposure necessary Reaction is milder or absent upon repeated exposures Spontaneous resolution Szebeni J. Toxicology 2005:216: Note that prior allergic reaction is contra-indication to use of same/similar agent 28

29 Event Rates for Commonly Performed Cardiovascular Procedures Procedure Event Rate Event Coronary Angiography Exercise Treadmill Testing 1:1000 Death 1:2500 MI or Death SPECT Exam or Radionuclide Ventriculography 1:1000 to 1:10,000 Fatal Malignancy Contrast Echocardiography 1:500,000 Death Pulmonary Hypertension 29

30 Using propensity matching, CE associated with a 28% lower mortality at 48 h in comparison with patients undergoing ntte Main ML, Hibberd MG, Ryan A, Lowe TJ, Miller P, Bhat G. Acute mortality in critically ill patients undergoing echocardiography with or without an ultrasound contrast agent. JACC Cardiovascular imaging 2014;7:

31 Interatrial Shunt Parker JM et al. Am J Cardiol2013;112:

32 Kalra A et al. JACC Cardiovasc Imaging 2014;7: Cost-effectiveness 32

33 Thx to Michael Main Outcomes Cost effectiveness Impact on therapeutic strategy Impact on diagnostic and prognostic thinking Diagnostic capacity Technical capability and Operational excellence Guyatt GH, Tugwell PX, Feeny DH, Haynes RB, Drummond M. A framework for clinical evaluation of diagnostic technologies. CMAJ 1986; 134: Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making 1991; 11:

34 And yet contrast is underutilized Contrast Echocardiography as a Percentage of Total Echocardiography 5.00% 4.50% 4.00% 3.50% 3.00% 2.50% 2.00% 1.50% 1.00% 0.50% 0.00% FDA Black Box Warning *through June 2015 Thx to Michael Main Arlington Medical Resources 34

35 Obstacles Internal (Lab operations) Time Orders Consent Personnel with IV skills / Scope of practice Access to agent External Cost considerations Black box warning STREAMLINE Decision Order/ Consent Personnel Agent Machine Optimization / Protocols 35

36 Decision Order/ Consent Personnel Agent Machine Optimization/ Protocols Decision Order/ Consent Personnel Agent Machine Optimization/ Protocols 36

37 Reduce/eliminate time to obtain order Incorporate order for contrast into order for echocardiogram Standing orders a written document containing rules, policies, procedures, regulations, and orders for the conduct of patient care in various stipulated clinical situations Develop policy for consent Order/ Decision Consent Personnel Agent Machine Optimization/ Protocols 37

38 Have ready access to personnel trained to insert IV and administer agent Create staffing model that ensures that echo labs have qualified non-sonographer personnel available» RN»?Cardiology fellow Cross-train sonographers ( scope of practice/personal preference) In hospital on floors In-service for nursing staff Decision Order/Conse nt Personnel Agent Machine Optimization / Protocols 38

39 Have ready access to agent/equipment Consider storing in high use sites (ICU s) Decision Order/Cons ent Personnel Agent Machine Optimization/ Protocols 39

40 Optimize machine settings Presets Agent specific Transducer specific Frequency specific Focal zone Protocols Infusion rate Look at more than the LV blood pool RV Great vessels Doppler Resource person 40

41 Cost Considerations There is inadequate reimbursement to cover the cost of contrast Solutions: For outpatient studies, there is reimbursement Document guideline driven indication For inpatient studies, cost of agent can be recaptured by reduction in other costs Create/defend contrast budget Indication for Study With thanks to Jonathan Lindner Chest pain - angina? LV Thrombus Stress echo DLVEF (chemo) Quality of Images poor fair good LVEF for ICD or BiV Dyspnea Hypotension Aortic dissection Atrial fibrillation Valve disease Pericardial disease 41

42 Summary Contrast has been repeatedly shown to improve the accuracy and reproducibility of LV volume /EF assessment Multiple off label uses Safety profile is excellent After hit triggered by black box warning utilization is increasing Summary Thoughtful approach to streamlining all steps in utilization chain is essential to optimal utilization and appropriate use of health care resources 42

43 43

Steven J. Lester, MD, FACC, FRCP(C), FASE Mayo Clinic. Relevant Financial Relationship(s) None. Off Label Usage

Steven J. Lester, MD, FACC, FRCP(C), FASE Mayo Clinic. Relevant Financial Relationship(s) None. Off Label Usage Steven J. Lester, MD, FACC, FRCP(C), FASE Mayo Clinic Relevant Financial Relationship(s) None Off Label Usage 1 2 1. Define ultrasound contrast? 2. Recognize the interaction of the bubbles with ultrasound

More information

Basics of Contrast Echocardiography Echo Hawaii 2017

Basics of Contrast Echocardiography Echo Hawaii 2017 Basics of Contrast Echocardiography Echo Hawaii 2017 Maryellen Orsinelli, RN, RDCS, FASE Lead Cardiac Sonographer The Ohio State University The Ross Heart Hospital 1 DISCLOSURES NONE 1 OBJECTIVES Indications

More information

CONTRAST ECHOCARDIOGRAPHY

CONTRAST ECHOCARDIOGRAPHY CONTRAST ECHOCARDIOGRAPHY How Should it Be Administered and How Do I Optimize My Machine Settings? Keith Collins, MS RDCS FASE Monday, Feb. 15, 2016 State of the Art Tscc.exe Contrast Is Needed When Poor

More information

Basics and Perfusion Imaging. Steven J. Lester, MD, FACC, FRCP(C), FASE Mayo Clinic, Arizona

Basics and Perfusion Imaging. Steven J. Lester, MD, FACC, FRCP(C), FASE Mayo Clinic, Arizona Basics and Perfusion Imaging Steven J. Lester, MD, FACC, FRCP(C), FASE Mayo Clinic, Arizona Relevant Financial Relationship(s) None Off Label Usage a. Produce only a harmonic backscatter signal. b. Produce

More information

Top 10 Facts in Contrast Echocardiography. Pamela R. Burgess, BS, RDCS, RDMS, RVT, FASE

Top 10 Facts in Contrast Echocardiography. Pamela R. Burgess, BS, RDCS, RDMS, RVT, FASE Top 10 Facts in Contrast Echocardiography Pamela R. Burgess, BS, RDCS, RDMS, RVT, FASE Presenter Disclosure The following relationship exist related to this presentation: Pamela R. Burgess, BS, RDCS, RDMS,

More information

Myocardial Contrast Echo

Myocardial Contrast Echo Myocardial Contrast Echo Anthony DeMaria Myocardial Contrast Echocardiography: Problems and Potential Anthony DeMaria MD Judith and Jack White Chair Founding Director, Sulpizio Cardiovascular Center University

More information

Disclosures. Stress Echocardiography 2010 Appropriate Use & Further Applications. Stress Echo Clinical Utility 9/8/10

Disclosures. Stress Echocardiography 2010 Appropriate Use & Further Applications. Stress Echo Clinical Utility 9/8/10 2010 & Further Applications Disclosures None Geoffrey A. Rose, MD FACC FASE Director, Cardiac Ultrasound Laboratory Sanger Heart & Vascular Institute Clinical Utility and Event-free Survival Cortigiani,

More information

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies Mitral Regurgitation The New ASE Guidelines: Role of 2D/3D and CMR William A. Zoghbi MD, FASE, MACC Professor and

More information

Detailed Order Request Checklists for Cardiology

Detailed Order Request Checklists for Cardiology Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2018

More information

ROLE OF CONTRAST AGENTS TO ENHANCE WALL MOTION AND DOPPLER SIGNALS

ROLE OF CONTRAST AGENTS TO ENHANCE WALL MOTION AND DOPPLER SIGNALS ROLE OF CONTRAST AGENTS TO ENHANCE WALL MOTION AND DOPPLER SIGNALS Adj Assoc Prof. Tong Khim Leng MBBS MRCP FAMS FACC FASE FRCP Chief, and Sn Consultant Department of Cardiology, Changi General Hospital

More information

Mechanisms and role of contrast echocardiography

Mechanisms and role of contrast echocardiography Mechanisms and role of contrast echocardiography Seol Sang-Hoon Inje University College of Medicine, Haeundae Paik Hospital, Busan, Korea Physical Principles of Contrast Ultrasound Contrast echocardiography

More information

What s New in Cardiac MRI

What s New in Cardiac MRI What s New in Cardiac MRI Katie M. Hawthorne, MD Director, Cardiac MRI Main Line Health Philadelphia Cardiovascular Summit November 18, 2017 Cardiac MRI: Disclosure 2 Disclosures No financial disclosures

More information

Contrast Echocardiography. What is the critical need? Meets a critical need! Cavity Opacification. What contrast is approved for: chamber assessment?

Contrast Echocardiography. What is the critical need? Meets a critical need! Cavity Opacification. What contrast is approved for: chamber assessment? Contrast Echocardiography for LV Opacification Natesa G. Pandian What contrast is approved for: Cavity Opacification Meets a critical need! Disclosure: Speakers Bureau, Lantheus Inc What is the critical

More information

The Normal Echocardiogram

The Normal Echocardiogram The Normal Echocardiogram Pravin V. Patil, MD FACC Lewis Katz School of Medicine at Temple University Acknowledgments Dr. Susan Wiegers Dr. Martin Keane Temple Cardiac Sonographers Disclosures No relevant

More information

Adult Echocardiography Examination Content Outline

Adult Echocardiography Examination Content Outline Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,

More information

Qualitative and Quantitative Assessment of Perfusion

Qualitative and Quantitative Assessment of Perfusion APCDE 2011 Qualitative and Quantitative Assessment of Perfusion Hyun Ju Yoon Chonnam National University Hospital Gwangju, Korea ISCHEMIC CASCADE Blood flow mismatch Perfusion defects on nuclear imaging,

More information

7. Echocardiography Appropriate Use Criteria (by Indication)

7. Echocardiography Appropriate Use Criteria (by Indication) Criteria for Echocardiography 1133 7. Echocardiography Criteria (by ) Table 1. TTE for General Evaluation of Cardiac Structure and Function Suspected Cardiac Etiology General With TTE 1. Symptoms or conditions

More information

Stress Echocardiography: Illustrative Cases Sunil Mankad, MD, FACC, FCCP, FASE Associate Professor of Medicine Mayo Clinic College of Medicine Director, Transesophageal Echocardiography Associate Director,

More information

Stable Angina: Indication for revascularization and best medical therapy

Stable Angina: Indication for revascularization and best medical therapy Stable Angina: Indication for revascularization and best medical therapy Cardiology Basics and Updated Guideline 2018 Chang-Hwan Yoon, MD/PhD Cardiovascular Center, Department of Internal Medicine Bundang

More information

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction Role of Stress Echo in Valvular Heart Disease ECHO HAWAII January 15 19, 2018 Kenya Kusunose, MD, PhD, FASE Tokushima University Hospital Japan Not only ischemia! Cardiomyopathy Prosthetic Valve Diastolic

More information

Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures?

Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures? Keenan Research Centre Li Ka Shing Knowledge Institute Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures? Howard Leong-Poi, MD, FRCPC Associate Professor of Medicine St.

More information

Concepts of Imaging and Knobology

Concepts of Imaging and Knobology Concepts of Imaging and Knobology Pravin Patil, MD FACC FASE Associate Professor of Medicine Director, Cardiovascular Disease Training Program Lewis Katz School of Medicine at Temple University Disclosures

More information

Cardiovascular Imaging Stress Echo

Cardiovascular Imaging Stress Echo Cardiovascular Imaging Stress Echo Theodora A Zaglavara, MD, PhD Cardiac Imaging Department INTERBALKAN MEDICAL CENTER Thessaloniki GREECE Evolution of Stress Echo: From Innovation to a Widely Established

More information

2019 Qualified Clinical Data Registry (QCDR) Performance Measures

2019 Qualified Clinical Data Registry (QCDR) Performance Measures 2019 Qualified Clinical Data Registry (QCDR) Performance Measures Description: This document contains the 18 performance measures approved by CMS for inclusion in the 2019 Qualified Clinical Data Registry

More information

You Won t Believe What I Saw on. Disclosures. Goals. Dimensions 2013 October 18 th Michael Pfeiffer, MD. No Financial Disclosures

You Won t Believe What I Saw on. Disclosures. Goals. Dimensions 2013 October 18 th Michael Pfeiffer, MD. No Financial Disclosures You Won t Believe What I Saw on that ECHO! Dimensions 2013 October 18 th Michael Pfeiffer, MD Disclosures No Financial Disclosures Goals Review unusual and unique echocardiographic images. Briefly present

More information

«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer

«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer «Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer Philippe Pibarot, DVM, PhD, FACC, FAHA, FESC, FASE Canada Research Chair in Valvular Heart Diseases Université LAVAL

More information

TAVR: Echo Measurements Pre, Post And Intra Procedure

TAVR: Echo Measurements Pre, Post And Intra Procedure 2017 ASE Florida, Orlando, FL October 10, 2017 8:00 8:25 AM 25 min TAVR: Echo Measurements Pre, Post And Intra Procedure Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology Echo Lab Associate

More information

When Should I Order a Stress Test or an Echocardiogram

When Should I Order a Stress Test or an Echocardiogram When Should I Order a Stress Test or an Echocardiogram Updates in Cardiology 2015 March 7, 2015 Donald L. Lappé, MD, FAHA, FACC Chairman, Cardiovascular Department Medical Director, Intermountain Cardiovascular

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acute coronary syndrome(s), anticoagulant therapy in, 706, 707 antiplatelet therapy in, 702 ß-blockers in, 703 cardiac biomarkers in,

More information

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED) A Light in the Dark: Cardiac MRI and Risk Mitigation J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED) Dr. Mikolich has NO financial disclosures relative to

More information

DECLARATION OF CONFLICT OF INTEREST

DECLARATION OF CONFLICT OF INTEREST DECLARATION OF CONFLICT OF INTEREST The additive prognostic value of myocardial perfusion defects, coronary flow reserve and wall motion abnormalities during dipyridamole contrast stress-echo: a prospective

More information

Comments restricted to Sapien and Corevalve 9/12/2016. Disclosures: Core Lab contracts with Edwards Lifesciences, Middlepeak, Medtronic

Comments restricted to Sapien and Corevalve 9/12/2016. Disclosures: Core Lab contracts with Edwards Lifesciences, Middlepeak, Medtronic Para-ValvularRegurgitation post TAVR: Predict, Prevent, Quantitate, Manage Linda D. Gillam, MD, MPH, FACC, FASE Chair, Department of Cardiovascular Medicine Morristown Medical Center/Atlantic Health System

More information

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef Review of Cardiac Imaging Modalities in the Renal Patient George Youssef ECHO Left ventricular hypertrophy (LVH) assessment Diastolic dysfunction Stress ECHO Cardiac CT angiography Echocardiography - positives

More information

Current Indications for Cardiac MRI: What You See is What You Get?

Current Indications for Cardiac MRI: What You See is What You Get? Current Indications for Cardiac MRI: What You See is What You Get? Javier Ganame, MD, PhD, FASE No disclosures Cardiology Update, Niagara, Sept 24th, 2016 The Ideal Diagnostic Technique Easy to apply Accurate

More information

Echo in the Emergency Room: Who Does It and To Whom?

Echo in the Emergency Room: Who Does It and To Whom? Echo in the Emergency Room: Who Does It and To Whom? Vera H. Rigolin, MD Professor of Medicine Northwestern University Feinberg School of Medicine Medical Director, Echocardiography Laboratory Northwestern

More information

Imaging of the Heart Todd Tessendorf MD FACC

Imaging of the Heart Todd Tessendorf MD FACC Imaging of the Heart Todd Tessendorf MD FACC Outline Imaging Modalities for Structural Heart Disease ECHO, MRI Imaging Modalities for Ischemic Heart Disease SPECT, PET, CCTA Show lots of pretty pictures

More information

Case Report. Case Report. Ana Lúcia Martins Arruda, Altamiro Ozório, Eloisa Mattos, José Lázaro de Andrade, Thomas Porter, Wilson Mathias Jr

Case Report. Case Report. Ana Lúcia Martins Arruda, Altamiro Ozório, Eloisa Mattos, José Lázaro de Andrade, Thomas Porter, Wilson Mathias Jr Case Report Hypoperfusion of the Left Ventricle in the Absence of Changes in Segmental Contractility as Observed through Echocardiography by Using Microbubbles During Dobutamine Infusion Ana Lúcia Martins

More information

My Patient Needs a Stress Test

My Patient Needs a Stress Test My Patient Needs a Stress Test Amy S. Burhanna,, MD, FACC Coastal Cardiology Cape May Court House, New Jersey Absolute and relative contraindications to exercise testing Absolute Acute myocardial infarction

More information

THE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS

THE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS 88 th ASMA ANNUAL SCIENTIFIC MEETING DENVER - CO April 30- May 4, 2017 THE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS S. BISCONTE (1), J. MONIN (2), N. HUIBAN (3), G. GUIU (2), S. NGUYEN (1), O.

More information

Cardiac Stress MRI: Detection of Ischemia. Disclosures: Dobutamine Stress MR. April 28, 2018

Cardiac Stress MRI: Detection of Ischemia. Disclosures: Dobutamine Stress MR. April 28, 2018 Cardiac MRI: Detection of Ischemia Cardiac MRI in Today s Clinical Practice Foundations of Cardiovascular Magnetic Resonance Daniel C. Lee, MD, MSc Assistant Professor of Medicine and Radiology Co-Director,

More information

Left atrial function. Aliakbar Arvandi MD

Left atrial function. Aliakbar Arvandi MD In the clinic Left atrial function Abstract The left atrium (LA) is a left posterior cardiac chamber which is located adjacent to the esophagus. It is separated from the right atrium by the inter-atrial

More information

3D-stress echocardiography Bernard Cosyns, MD, PhD

3D-stress echocardiography Bernard Cosyns, MD, PhD 3D-stress echocardiography Bernard Cosyns, MD, PhD No Disclosure The Pro-Technology bias Sicari et al. Cardiovascular Ultrasound 2006, 4:11 Overview 2D stress echocardiography: main limitations 3D echocardiography:

More information

Michigan Society of Echocardiography ECHO IN SLOPES How We Do It? Accelerated Dobutamine Echocardiography Henry Ford Initial Experience

Michigan Society of Echocardiography ECHO IN SLOPES How We Do It? Accelerated Dobutamine Echocardiography Henry Ford Initial Experience Michigan Society of Echocardiography ECHO IN SLOPES 2012 How We Do It? Accelerated Dobutamine Echocardiography Henry Ford Initial Experience Karthik Ananthasubramaniam, MD FRCP FACC FASE FASNC Associate

More information

Power Doppler Myocardial Contrast Echocardiography Using an Improved Multiple Frame Triggered Harmonic Angio Technique

Power Doppler Myocardial Contrast Echocardiography Using an Improved Multiple Frame Triggered Harmonic Angio Technique Reprinted with permission from ECHOCARDIOGRAPHY, Volume 18, No. 3, April 2001 Copyright 2001 by Futura Publishing Company, Inc., Armonk, NY 10504-0418 Power Doppler Myocardial Contrast Echocardiography

More information

CT FFR: Are you ready to totally change the way you diagnose Coronary Artery Disease?

CT FFR: Are you ready to totally change the way you diagnose Coronary Artery Disease? CT FFR: Are you ready to totally change the way you diagnose Coronary Artery Disease? Madan Mohan MD MRCP FACC CQO, Division of Cardiovascular Medicine University Hospitals Case Medical Center Assistant

More information

An EMR Specifically Designed for the Cardiovascular Practice

An EMR Specifically Designed for the Cardiovascular Practice An EMR Specifically Designed for the Cardiovascular Practice Gary Chaisson RTR, RCSA Co-Founder Objective Medical Systems May 30, 2017 Disclosure Major Shareholder Objective Medical Systems EMR History

More information

411.1 INTERMED CORONARY SYNDROME 412 OLD MYOCARDIAL INFARCT ANGINA PECTORIS OT/UNSPEC CORONARY ATHRSCL UNS VESSEL

411.1 INTERMED CORONARY SYNDROME 412 OLD MYOCARDIAL INFARCT ANGINA PECTORIS OT/UNSPEC CORONARY ATHRSCL UNS VESSEL 78451 Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative NUC 1073 410.91 AMI UNSP INITIAL EPISODE 410.92 AMI UNSP SUBSEQUENT EPISODE 414.8 CHR ISCHEMIC HRT

More information

Echocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction

Echocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction Echocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction October 4, 2014 James S. Lee, M.D., F.A.C.C. Associates in Cardiology, P.A. Silver Spring, M.D. Disclosures Financial none

More information

CONTRAST ENHANCED IMAGING HOW TO GET STARTED: A Tale From A Facility Like Yours

CONTRAST ENHANCED IMAGING HOW TO GET STARTED: A Tale From A Facility Like Yours The presentation will begin in a few moments. CONTRAST ENHANCED IMAGING HOW TO GET STARTED: A Tale From A Facility Like Yours For technical support, call 800-679-3646 CONTRAST ENHANCED IMAGING HOW TO GET

More information

Cases in Stress Echo DISCLOSURE

Cases in Stress Echo DISCLOSURE Cases in Stress Echo Susan Wilansky, MD, FRCP(C), FACC, FASE Mayo Clinic, AZ DISCLOSURE Relevant Financial Relationship(s) None Off Label Usage None 1 Exercise Testing in Patients with HCM (Class IIa)

More information

Complications of Myocardial Infarction

Complications of Myocardial Infarction Complications of Myocardial Infarction Sunil Mankad, MD, FACC, FCCP, FASE Associate Professor of Medicine Mayo Clinic College of Medicine Director, Transesophageal Echocardiography Associate Director,

More information

Getting the Most Out of Stress Echo

Getting the Most Out of Stress Echo Getting the Most Out of Stress Echo Vera H. Rigolin, MD, FASE, FACC, FAHA Professor of Medicine Northwestern University Feinberg School of Medicine Medical Director, Echocardiography Laboratory Northwestern

More information

Choosing the Appropriate Stress Test: Brett C. Stoll, MD, FACC February 24, 2018

Choosing the Appropriate Stress Test: Brett C. Stoll, MD, FACC February 24, 2018 Choosing the Appropriate Stress Test: Brett C. Stoll, MD, FACC February 24, 2018 Choosing the Appropriate Stress Test: Does it Really Matter? Brett C. Stoll, MD, FACC February 24, 2018 Conflicts of Interest

More information

ASE 2011 Appropriate Use Criteria for Echocardiography

ASE 2011 Appropriate Use Criteria for Echocardiography ASE 2011 Appropriate Use Criteria for Echocardiography Table 1. TTE for General Evaluation of Cardiac Structure and Function 1 2 Suspected Cardiac Etiology General With TTE Symptoms or conditions potentially

More information

Competency Training Requirements for the Area of Focused Competence in Adult Echocardiography

Competency Training Requirements for the Area of Focused Competence in Adult Echocardiography Competency Training Requirements for the Area of Focused Competence in Adult Echocardiography 2013 VERSION 1.0 These training requirements apply to those who begin training on or after July 1 st, 2013.

More information

J. Schwitter, MD, FESC Section of Cardiology

J. Schwitter, MD, FESC Section of Cardiology J. Schwitter, MD, FESC Section of Cardiology CMR Center of the CHUV University Hospital Lausanne - CHUV Switzerland Centre de RM Cardiaque J. Schwitter, MD, FESC Section of Cardiology CMR Center of the

More information

Patient-Reported Outcomes: A Critical Insight into the Impact of Therapy

Patient-Reported Outcomes: A Critical Insight into the Impact of Therapy Patient-Reported Outcomes: A Critical Insight into the Impact of Therapy John Spertus MD MPH Missouri/Lauer Endowed Chair and Professor, UMKC Saint Luke s Mid America Heart Institute Presentation Overview

More information

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators Paris, August 28 th 2011 Is TAVI the definitive treatment in high risk patients? Impact Of Coronary Artery Disease In Elderly Patients Undergoing TAVI: Insight The Italian CoreValve Registry Gian Paolo

More information

QCVC Committees Scientific Activities Central Hall General Information FAC. SPECT tomography has the advantage of quantifying biventricular volumes.

QCVC Committees Scientific Activities Central Hall General Information FAC. SPECT tomography has the advantage of quantifying biventricular volumes. QCVC Committees Scientific Activities Central Hall General Information FAC Thematic Units Arrhythmias and Electrophysiology Basic Research Bioengineering and Medical Informatics Cardiac Surgical Intensive

More information

Νεότερα ςτην Υπερηχοκαρδιογραφία. Βαςίλειοσ Καμπερίδησ Clinical research fellow in Cardiology

Νεότερα ςτην Υπερηχοκαρδιογραφία. Βαςίλειοσ Καμπερίδησ Clinical research fellow in Cardiology Νεότερα ςτην Υπερηχοκαρδιογραφία Βαςίλειοσ Καμπερίδησ Clinical research fellow in Cardiology Disclosures ESC training grant EACVI research grant HCS training grant ELIKAR research grant Evolution of Echocardiography

More information

Echocardiography has been widely used as a. Contrast Microbubbles Improve Diagnostic Yield in ICU Patients With Poor Echocardiographic Windows*

Echocardiography has been widely used as a. Contrast Microbubbles Improve Diagnostic Yield in ICU Patients With Poor Echocardiographic Windows* Contrast Microbubbles Improve Diagnostic Yield in ICU Patients With Poor Echocardiographic Windows* Thanh T. Nguyen, DO; Milind R. Dhond, MD; Raju Sabapathy, MD; and William J. Bommer, MD Objective: To

More information

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Measure Set Quality Payment Program: Cardiology Specialty Set Title Number CMS Reporting Method(s) Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for

More information

Chapter 5 Section 1.1

Chapter 5 Section 1.1 Radiology Chapter 5 Section 1.1 Issue Date: March 7, 1986 Authority: 32 CFR 199.4(a), (b)(2)(x), (c)(2)(viii), (e)(14) and 32 CFR 199.6(d)(2) Copyright: CPT only 2006 American Medical Association (or such

More information

Case based learning: CMR in Heart Failure

Case based learning: CMR in Heart Failure Case based learning: CMR in Heart Failure Milind Y Desai, MD FACC FAHA FESC Associate Professor of Medicine Heart and Vascular Institute, Cleveland Clinic Cleveland, OH Disclosures: none Use of Gadolinium

More information

powerful versatile mobile

powerful versatile mobile M9 Premium Compact Ultrasound System powerful versatile mobile M9 Premium Compact Ultrasound System powerful versatile mobile Powerful Platform With the next generation of technologies, the Mindray M9

More information

Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter

Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter Nirat Beohar, MD Associate Professor of Medicine Director Cardiac Catheterization Laboratory, Medical Director Structural

More information

Treatment of Hypertrophic Cardiomyopathy in Bruce B. Reid, MD

Treatment of Hypertrophic Cardiomyopathy in Bruce B. Reid, MD Treatment of Hypertrophic Cardiomyopathy in 2017 Bruce B. Reid, MD Disclosures I have no conflicts of interest to disclose I will not be discussing any off label medications and/or devices Objectives 1)

More information

Pregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016

Pregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016 1 Pregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016 DISCLOSURES I have no disclosures relevant to today s talk 2 Cardiovascular Effects of Pregnancy Anatomic Ventricular muscle mass increases

More information

Heart Failure in 2012 with reference to NICE Guidance Dr Maurice Pye Consultant Cardiologist York District Hospital

Heart Failure in 2012 with reference to NICE Guidance Dr Maurice Pye Consultant Cardiologist York District Hospital Heart Failure in 2012 with reference to NICE Guidance 2010 Dr Maurice Pye Consultant Cardiologist York District Hospital A little over elaborate,do not include ECG or CXR If clinical suspicion is high

More information

Ultrasound 10/1/2014. Basic Echocardiography for the Internist. Mechanical (sector) transducer Piezoelectric crystal moved through a sector sweep

Ultrasound 10/1/2014. Basic Echocardiography for the Internist. Mechanical (sector) transducer Piezoelectric crystal moved through a sector sweep Ultrasound Basic Echocardiography for the Internist Carol Gruver, MD, FACC UT Erlanger Cardiology Mechanical wave of compression and rarefaction Requires a medium for transmission Ultrasound frequency

More information

Value of echocardiography in chronic dyspnea

Value of echocardiography in chronic dyspnea Value of echocardiography in chronic dyspnea Jahrestagung Schweizerische Gesellschaft für /Schweizerische Gesellschaft für Pneumologie B. Kaufmann 16.06.2016 Chronic dyspnea Shortness of breath lasting

More information

Chapter 5 Section 1.1. Diagnostic Radiology (Diagnostic Imaging)

Chapter 5 Section 1.1. Diagnostic Radiology (Diagnostic Imaging) Radiology Chapter 5 Section 1.1 Issue Date: March 7, 1986 Authority: 32 CFR 199.4(a), (b)(2)(x), (c)(2)(viii), (e)(14) and 32 CFR 199.6(d)(2) 1.0 CPT 1 PROCEDURE CODES 70010-72292, 73000-76499, 77071-77084,

More information

Low Gradient Severe AS: Who Qualifies for TAVR? Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor

Low Gradient Severe AS: Who Qualifies for TAVR? Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Low Gradient Severe AS: Who Qualifies for TAVR? Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central Michigan University

More information

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED) A Light in the Dark: Cardiac MRI and Risk Mitigation J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED) Dr. Mikolich has NO financial disclosures relative to

More information

Role of Stress Echo in Valvular Heart Disease. Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan

Role of Stress Echo in Valvular Heart Disease. Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan Role of Stress Echo in Valvular Heart Disease Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan Exercise echocardiography Dobutamine echocardiography Usefulness of exercise echo

More information

Quantifying Aortic Regurgitation

Quantifying Aortic Regurgitation Quantifying Aortic Regurgitation Linda D. Gillam, MD, MPH Morristown Medical Center Dorothy and Lloyd Huck Chair Cardiovascular Medicine Atlantic Health System No Disclosures 1 Valve Dysfunction Functional

More information

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute 62 year old male Anterior STEMI late presentation, occluded

More information

Chapter 6: Summary

Chapter 6: Summary Chapter 6: Summary The present thesis describes several clinical studies on the topic of intravenous myocardial contrast echocardiography, and an experimental study on the effect of ultrasound contrast

More information

Athlete s Heart vs. Cardiomyopathy

Athlete s Heart vs. Cardiomyopathy Athlete s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular Service Line Former Team Cardiologist to the New York Jets

More information

Strain Imaging: Myocardial Mechanics Simplified and Applied

Strain Imaging: Myocardial Mechanics Simplified and Applied 9/28/217 Strain Imaging: Myocardial Mechanics Simplified and Applied John Gorcsan III, MD Professor of Medicine Director of Clinical Research Division of Cardiology VECTORS OF CONTRACTION Shortening Thickening

More information

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection

More information

10/7/2013. Systolic Function How to Measure, How Accurate is Echo, Role of Contrast. Thanks to our Course Director: Neil J.

10/7/2013. Systolic Function How to Measure, How Accurate is Echo, Role of Contrast. Thanks to our Course Director: Neil J. Systolic Function How to Measure, How Accurate is Echo, Role of Contrast Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University Washington, D.C. No Disclosures

More information

A case of post myocardial infarction ventricular septal rupture CHRISTOFOROS KOBOROZOS, MD

A case of post myocardial infarction ventricular septal rupture CHRISTOFOROS KOBOROZOS, MD A case of post myocardial infarction ventricular septal rupture CHRISTOFOROS KOBOROZOS, MD NAVAL HOSPITAL OF ATHENS case presentation Female, 81yo Hx: diabetes mellitus, hypertension, chronic anaemia presented

More information

HFpEF. April 26, 2018

HFpEF. April 26, 2018 HFpEF April 26, 2018 (J Am Coll Cardiol 2017;70:2476 86) HFpEF 50% or more (40-71%) of patients with CHF have preserved LV systolic function. HFpEF is an increasingly frequent hospital discharge. Outcomes

More information

Cardiovascular Imaging Endpoints in Oncology Clinical Trials

Cardiovascular Imaging Endpoints in Oncology Clinical Trials Cardiovascular Imaging Endpoints in Oncology Clinical Trials Bonnie Ky, MD, MSCE Assistant Professor of Medicine and Epidemiology Director, Penn Cardio-Oncology Center of Excellence Director, Penn Center

More information

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology Managing Hypertrophic Cardiomyopathy with Imaging Gisela C. Mueller University of Michigan Department of Radiology Disclosures Gadolinium contrast material for cardiac MRI Acronyms Afib CAD Atrial fibrillation

More information

Stress, strain and contrast. UK available agents. Safety 13/06/2018. Which enhancing agent do you use? Ultrasound enhancing agents.

Stress, strain and contrast. UK available agents. Safety 13/06/2018. Which enhancing agent do you use? Ultrasound enhancing agents. Stress, strain and contrast Stephen Glen Ultrasound enhancing agents Safety Effectiveness during stress Perfusion / myocardial contrast UK available agents Which enhancing agent do you use? Name Bubble

More information

STANDARDIZED PROCEDURE CARDIAC STRESS TESTING-EXERCISE TESTING (Adult)

STANDARDIZED PROCEDURE CARDIAC STRESS TESTING-EXERCISE TESTING (Adult) 1 I. Definition: During the exercise test, the patient exercises on a bike or treadmill while being monitored with a 12 lead ECG, blood pressure device, pulse oximetry oxygen consumption, and perhaps imaging

More information

The new Guidelines: Focus on Chronic Heart Failure

The new Guidelines: Focus on Chronic Heart Failure The new Guidelines: Focus on Chronic Heart Failure Petros Nihoyannopoulos MD, FRCP, FESC Professor of Cardiology Imperial College London and National & Kapodistrian University of Athens 2 3 4 The principal

More information

Δυναμική υπερηχοκαρδιογραφία στις μυοκαρδιοπάθειες : έχει θέση και ποια ;

Δυναμική υπερηχοκαρδιογραφία στις μυοκαρδιοπάθειες : έχει θέση και ποια ; Ελληνική Καρδιολογική Εταιρεία Σεμινάρια ομάδων εργασίας Θεσσαλονίκη, 8-10 Φεβρουαρίου 2018 Ομάδα εργασίας Ηχωκαρδιολογίας Δυναμική υπερηχοκαρδιογραφία στις μυοκαρδιοπάθειες : έχει θέση και ποια ; ΑΓΑΘΗ-ΡΟΖΑ

More information

Cardiogenic Shock. Carlos Cafri,, MD

Cardiogenic Shock. Carlos Cafri,, MD Cardiogenic Shock Carlos Cafri,, MD SHOCK= Inadequate Tissue Mechanisms: Perfusion Inadequate oxygen delivery Release of inflammatory mediators Further microvascular changes, compromised blood flow and

More information

Clinical Applications of Ultrasonic Contrast Agents in Echocardiography

Clinical Applications of Ultrasonic Contrast Agents in Echocardiography Author: Sherif F. Nagueh, MD,FACC, FAHA, FASE TABLE OF CONTENTS Faculty Disclosure page 1 Accreditation page 2 Biography page 3 Learning Objectives page 4 Introduction page 5 Conclusions page 11 Figures

More information

Cardiomyopathy. Cardiomyopathies HOCM. Hypertrophic Obstructive Cardiomyopathy. Systolic Anterior Movement (SAM) of Mitral Valve (Venturi Effect) Cine

Cardiomyopathy. Cardiomyopathies HOCM. Hypertrophic Obstructive Cardiomyopathy. Systolic Anterior Movement (SAM) of Mitral Valve (Venturi Effect) Cine Jens Bremerich Radiology University Hospital Basel Hypertrophic Obstructive Cine VENC Cine (5m/s) Modified Bernoulli Equation: P (in mmhg) = 4 x (Vmax)2 Vmax= 4.2 m/s, P = 70mm Hg Hydrodynamica 738 HOCM

More information

Chronic Primary Mitral Regurgitation

Chronic Primary Mitral Regurgitation Chronic Primary Mitral Regurgitation The Case For Early Surgical Intervention William K. Freeman, MD, FACC, FASE DISCLOSURES Relevant Financial Relationship(s) None Off Label Usage None Watchful Waiting......

More information

Emergency Echo, Emergency Setting, ABCD Approach

Emergency Echo, Emergency Setting, ABCD Approach ECHO Alex Conference 2010 Emergency Echo, Emergency Setting, ABCD Approach Aleksandar N. Nešković Clinical Hospital Center Zemun Belgrade University School of Medicine Emergency Echocardiography Why ECHO

More information

Rotation: Echocardiography: Transthoracic Echocardiography (TTE)

Rotation: Echocardiography: Transthoracic Echocardiography (TTE) Rotation: Echocardiography: Transthoracic Echocardiography (TTE) Rotation Format and Responsibilities: Fellows rotate in the echocardiography laboratory in each clinical year. Rotations during the first

More information

Catheter-based mitral valve repair MitraClip System

Catheter-based mitral valve repair MitraClip System Percutaneous Mitral Valve Repair: Results of the EVEREST II Trial William A. Gray MD Director of Endovascular Services Associate Professor of Clinical Medicine Columbia University Medical Center The Cardiovascular

More information

Cardiac Chamber Quantification by Echocardiography

Cardiac Chamber Quantification by Echocardiography Cardiac Chamber Quantification by Echocardiography Maryam Bokhamseen, RCS, RCDS, EACVI Echotechnologist ǁ, Non invasive Cardiac Laboratory King Abdulaziz Cardiac Center. Outline: Introduction. Background

More information

TREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA. IMP v4

TREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA. IMP v4 1 TREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA FDA APPROVES IMPELLA FOR HIGH-RISK PCI 2 Impella is the only hemodynamic support device proven safe and effective in elective

More information

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease 21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease Noninvasive Evaluation of Coronary Artery Disease: Anatomical, Functional, Clinical May 5, 2018 Mark Hansen MD FRCPC Cardiologist,

More information